Next Article in Journal
Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor
Previous Article in Journal
Comment on Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJNS
Volume 9
Issue 1
10.3390/ijns9010008
IJNS-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Reply to Int. J. Neonatal Screen. 2023, 9(1), 7.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Reply to Maase et al. Comment on “Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20”

by
Simon A. Jones
1,
David Cheillan
2,
Anupam Chakrapani
3,
Heather J. Church
1,
Simon Heales
4,
Teresa H. Y. Wu
1,
Georgina Morton
5,
Patricia Roberts
5,
Erica F. Sluys
6,† and
Alberto Burlina
7,*
1
Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, St Mary’s Hospital, Oxford Road, Manchester M13 9WL, UK
2
Service Biochimie et Biologie Moléculaire, Groupement Hospitalier Est, Hospices Civils de Lyon, 69002 Lyon, France
3
Department of Metabolic Medicine, Great Ormond Street Hospital NHS Foundation Trust, London WC1N 3JH, UK
4
Neurometabolic Unit, University College London Hospitals NHS Foundation Trust and Enzymes Laboratory, Great Ormond Street Hospital NHS Foundation Trust, London WC1N 3JH, UK
5
ArchAngel MLD Trust, Registered Charity No. 1157825, London W2 1DT, UK
6
Helvet Health, Ruelle de la Muraz 4, 1260 Nyon, Switzerland
7
Division of Inherited Metabolic Diseases, Reference Centre Expanded Newborn Screening, University Hospital Padova, 35128 Padova, Italy
*
Author to whom correspondence should be addressed.
†
Current address: Sluys Scientific, Chemin du Rayon de Soleil 10, 1260 Nyon, Switzerland.
Int. J. Neonatal Screen. 2023, 9(1), 8; https://doi.org/10.3390/ijns9010008
Submission received: 28 January 2023 / Accepted: 6 February 2023 / Published: 16 February 2023
Versions Notes
The commentary provided by Maase et al. [1] demonstrates how the novel algorithm [2] could be utilised by countries to evaluate disorders through expanded newborn screening programmes. We read with interest the detail provided about the Dutch evaluation method and appreciate the similarities described in their point-based scoring approach. We thank the authors for their comments.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Maase, R.; Jansen, M.E.; Heijnen, M.-L.; Dekkers, E. Comment on Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20. Int. J. Neonatal Screen. 2023, 9, 7. [Google Scholar] [CrossRef]
  2. Burlina, A.; Jones, S.A.; Chakrapani, A.; Church, H.J.; Heales, S.; Wu, T.H.Y.; Morton, G.; Roberts, P.; Sluys, E.F.; Cheillan, D. A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes. Int. J. Neonatal Screen. 2022, 8, 25. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jones, S.A.; Cheillan, D.; Chakrapani, A.; Church, H.J.; Heales, S.; Wu, T.H.Y.; Morton, G.; Roberts, P.; Sluys, E.F.; Burlina, A. Reply to Maase et al. Comment on “Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20”. Int. J. Neonatal Screen. 2023, 9, 8. https://doi.org/10.3390/ijns9010008

AMA Style

Jones SA, Cheillan D, Chakrapani A, Church HJ, Heales S, Wu THY, Morton G, Roberts P, Sluys EF, Burlina A. Reply to Maase et al. Comment on “Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20”. International Journal of Neonatal Screening. 2023; 9(1):8. https://doi.org/10.3390/ijns9010008

Chicago/Turabian Style

Jones, Simon A., David Cheillan, Anupam Chakrapani, Heather J. Church, Simon Heales, Teresa H. Y. Wu, Georgina Morton, Patricia Roberts, Erica F. Sluys, and Alberto Burlina. 2023. "Reply to Maase et al. Comment on “Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20”" International Journal of Neonatal Screening 9, no. 1: 8. https://doi.org/10.3390/ijns9010008

APA Style

Jones, S. A., Cheillan, D., Chakrapani, A., Church, H. J., Heales, S., Wu, T. H. Y., Morton, G., Roberts, P., Sluys, E. F., & Burlina, A. (2023). Reply to Maase et al. Comment on “Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20”. International Journal of Neonatal Screening, 9(1), 8. https://doi.org/10.3390/ijns9010008

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop